CTOs on the Move

OMNIlife science, Inc. (Main)

www.omnils.com

 
OMNIlife science, Inc. (Main) is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.omnils.com
  • 50 Oconnell Way
    East Taunton, MA USA '02718
  • Phone: 508.824.2444

Executives

Name Title Contact Details

Similar Companies

MIVI Neuroscience

MIVI Neuroscience, (MIVI) is an innovative medical device company that aims to achieve life-giving results for an increasing number of patients experiencing acute ischemic stroke (AIS).

Juvent Medical Inc

Juvent Medical Inc is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Applied Medical Resources Corporation

Applied Medical has developed strategic partnerships with a number of top research institutions and medical industry pioneers. The surgical equipment market is diverse and complex. Applied Medical is committed to working with our partners to provide

Zimmer Biomet

Zimmer Biomet is the world`s most trusted brand for personalized bone and joint healthcare solutions. We help people discover and achieve exceptional outcomes. As a leading innovator in musculoskeletal healthcare, we offer a complete portfolio of products for joint reconstruction, bone and skeletal repair, sports medicine, spine, and dental reconstruction.

Endologix

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is currently marketing the AFX® Endovascular AAA System is available in the U.S., Europe, Latin America and other regions. The Nellix® EndoVascular Aneurysm Sealing System, a novel aneurysm sealing system, is approved for sale in Europe and other markets and for investigational use in the U.S. The Powerlink with IntuiTrak® Delivery System is available in Japan. These technologies are minimally invasive, allowing for greater patient comfort and quicker recovery compared to invasive surgical alternatives. Endologix products are protected by at least 52 U.S. patents with at least 956 allowed claims. Endologix is a publicly-held company trading on NASDAQ: ELGX. The Company`s corporate office is located in Irvine, California.